ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

June 14, 2013

FDA Designates Zometa For Priority Review.

November 30, 2001

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

January 31, 2003

B.J. Kennedy, “Father of Medical Oncology,” Dead At 81

April 18, 2003

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010